Filing Details
- Accession Number:
- 0000937556-20-000191
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-17 17:23:09
- Reporting Period:
- 2020-12-15
- Accepted Time:
- 2020-12-17 17:23:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 937556 | Masimo Corp | MASI | Electromedical & Electrotherapeutic Apparatus (3845) | 330368882 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406493 | Anand Sampath | C/O Masimo Corporation 52 Discovery Irvine CA 92618 | Evp, Ops & Clinical Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-15 | 15,000 | $31.01 | 28,782 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-15 | 15,000 | $265.61 | 13,782 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-15 | 15,000 | $21.77 | 28,782 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-15 | 15,000 | $265.58 | 13,782 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2020-12-15 | 15,000 | $0.00 | 15,000 | $31.01 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2020-12-15 | 15,000 | $21.77 | 15,000 | $21.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-03-20 | 2025-03-20 | No | 4 | M | Direct |
| 15,204 | 2015-08-12 | 2024-08-12 | No | 4 | M | Direct |
Footnotes
- The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of November 11, 2020, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $262.41 per share to a high of $267.77 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $262.03 per share to a high of $267.68 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option was granted on March 20, 2015 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
- This option was granted on August 12, 2014 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
Billionaire Hedge Funds
